These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7659583)

  • 1. Effects of the pacing site, procainamide, and lead configuration on the relationship between the upper limit of vulnerability and the defibrillation threshold.
    Fan W; Gotoh M; Chen PS
    Pacing Clin Electrophysiol; 1995 Jun; 18(6):1279-84. PubMed ID: 7659583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of pacing rate and timing of defibrillation shock on the relation between the defibrillation threshold and the upper limit of vulnerability in open chest dogs.
    Chen PS; Feld GK; Mower MM; Peters BB
    J Am Coll Cardiol; 1991 Nov; 18(6):1555-63. PubMed ID: 1939961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Timing of the upper limit of vulnerability is different for monophasic and biphasic shocks: implications for the determination of the defibrillation threshold.
    Behrens S; Li C; Franz MR
    Pacing Clin Electrophysiol; 1997 Sep; 20(9 Pt 1):2179-87. PubMed ID: 9309741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of rapid pacing and T-wave scanning on the relation between the defibrillation and upper-limit-of-vulnerability dose-response curves.
    Malkin RA; Idriss SF; Walker RG; Ideker RE
    Circulation; 1995 Sep; 92(5):1291-9. PubMed ID: 7648678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of transvenous electrode polarity and waveform duration on the relationship between defibrillation threshold and upper limit of vulnerability.
    Huang J; KenKnight BH; Walcott GP; Rollins DL; Smith WM; Ideker RE
    Circulation; 1997 Aug; 96(4):1351-9. PubMed ID: 9286969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of lidocaine on relation between defibrillation threshold and upper limit of vulnerability in open-chest dogs.
    Topham SL; Cha YM; Peters BB; Chen PS
    Circulation; 1992 Mar; 85(3):1146-51. PubMed ID: 1537112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiological effects of monophasic and biphasic stimuli in normal and infarcted dogs.
    Wharton JM; Richard VJ; Murry CE; Dixon EG; Reimer KA; Meador J; Smith WM; Ideker RE
    Pacing Clin Electrophysiol; 1990 Sep; 13(9):1158-72. PubMed ID: 1700392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of acute and chronic defibrillation threshold with upper limit of vulnerability determined in normal sinus rhythm.
    Birgersdotter-Green U; Undesser K; Fujimura O; Feld GK; Kass RM; Mandel WJ; Peter CT; Chen PS
    J Interv Card Electrophysiol; 1999 Jul; 3(2):155-61. PubMed ID: 10387143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the defibrillation threshold and the upper limit of ventricular vulnerability.
    Chen PS; Shibata N; Dixon EG; Martin RO; Ideker RE
    Circulation; 1986 May; 73(5):1022-8. PubMed ID: 3698224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of procainamide on wave-front dynamics during ventricular fibrillation in open-chest dogs.
    Kwan YY; Fan W; Hough D; Lee JJ; Fishbein MC; Karagueuzian HS; Chen PS
    Circulation; 1998 May; 97(18):1828-36. PubMed ID: 9603538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of atrial refractoriness to upper and lower limits of vulnerability for atrial fibrillation/flutter following implantable ventricular defibrillator shocks.
    Katz A; Sweeney RJ; Gill RM; Reid PR; Prystowsky EN
    Circulation; 1999 Sep; 100(10):1125-30. PubMed ID: 10477539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved defibrillation efficacy with an ascending ramp waveform in humans.
    Shorofsky SR; Rashba E; Havel W; Belk P; Degroot P; Swerdlow C; Gold MR
    Heart Rhythm; 2005 Apr; 2(4):388-94. PubMed ID: 15851341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of pacing site on ventricular fibrillation initiation by shocks during the vulnerable period.
    Idriss SF; Wolf PD; Smith WM; Ideker RE
    Am J Physiol; 1999 Nov; 277(5):H2065-82. PubMed ID: 10564163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Internal cardioversion of atrial fibrillation in sheep.
    Cooper RA; Alferness CA; Smith WM; Ideker RE
    Circulation; 1993 May; 87(5):1673-86. PubMed ID: 8491023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of upper limit of vulnerability and defibrillation probability of success curves using a nonthoracotomy lead system.
    Souza JJ; Malkin RA; Ideker RE
    Circulation; 1995 Feb; 91(4):1247-52. PubMed ID: 7850965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of the defibrillation threshold using the upper limit of vulnerability following defibrillator implantation.
    Kirilmaz A; Dokumaci B; Uzun M; Kilicaslan F; Dinckal MH; Yucel O; Karaca M
    Pacing Clin Electrophysiol; 2005 Jun; 28(6):498-505. PubMed ID: 15955181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocardial pacing, cardioversion and defibrillation using a braided endocardial lead system.
    Saksena S; Luceri R; Krol RB; Brownstein S; Burkhardt E; Accorti P; Brewer G; Scott S; Callaghan F; Livingston A
    Am J Cardiol; 1993 Apr; 71(10):834-41. PubMed ID: 8456763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of epicardial patches on defibrillation threshold with nonthoracotomy lead configurations.
    Fotuhi PC; Ideker RE; Idriss SF; Callihan RL; Walker RG; Alt EU
    Circulation; 1995 Nov; 92(10):3082-8. PubMed ID: 7586279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination biphasic waveform plus sequential pulse defibrillation improves defibrillation efficacy of a nonthoracotomy lead system.
    Exner D; Yee R; Jones DL; Klein GJ; Mehra R
    J Am Coll Cardiol; 1994 Feb; 23(2):317-22. PubMed ID: 8294680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of ventricular fibrillation duration and site of initiation on the defibrillation threshold during early ventricular fibrillation.
    Strobel JS; Kenknight BH; Rollins DL; Smith WM; Ideker RE
    J Am Coll Cardiol; 1998 Aug; 32(2):521-7. PubMed ID: 9708486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.